Heartbeam, Inc. (BEAT)

NASDAQ

$0.69

$+0.28

(+64.52%)

Regular Market

Heartbeam, Inc. (BEAT) Live Price Chart

Last updated: ⁦2026-10-05 15:53:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Heartbeam, Inc. (BEAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.69, with a market capitalization of $24.49M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.36 to $4.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$24.49M
Open	$0.75
Day's High	$80.92
Day's Low	$0.36
Previous Close	$0.43
Volume	265.92M
Average Volume	662.41K
P/E Ratio	--
52-Week High	$4.00
52-Week Low	$0.36
Dividend Yield	--
Earnings Date	--

Heartbeam, Inc. (BEAT) Stock Price Today

Heartbeam, Inc. (BEAT) is currently trading at $0.69 as of 2026-10-05 15:36:38, up 59.23% ($0.26) from the previous close of $0.43

During today's regular trading session, BEAT has traded between $0.36 and $80.92, with a trading volume of 265.92M shares. The current price is near the lower end of today's range.

Heartbeam, Inc. (BEAT) 7-Day Stock Price Change

Over the past seven days, Heartbeam, Inc. (BEAT) moved from $0.38 to $0.69, representing a gain of 82.59% ($0.31).

The stock traded between $0.36 and $0.93 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 697.65 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

BEAT 52-Week Price Position

Position in Range: 9.2%

52W Low$0.36

52W High$4.00

BEAT is currently trading at $0.69, placing it 9.2% of the way from its 52-week low of $0.36 to its 52-week high of $4.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Heartbeam, Inc. (BEAT)?

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Heartbeam, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	16
Exchange	NASDAQ
Company Website	https://www.heartbeam.com

How to Buy Heartbeam, Inc. (BEAT) Stock on MEXC

Eligible investors can buy real shares of Heartbeam, Inc. (BEAT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BEAT and Place Your Order

Open the RealStocks trading page and search for BEAT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Heartbeam, Inc. (BEAT) stock price today?

Heartbeam, Inc. (BEAT) is currently trading at $ 0.69, up 59.23% ($0.26) from the previous close of $ 0.43. Intraday prices update in real time during regular trading hours.

2.Is BEAT stock going up or down today?

As of 2026-10-05 15:36:38, BEAT is trading at $ 0.69, up 59.23% ($0.26) from its previous close of $ 0.43. The stock has traded between $ 0.36 and $ 80.92 during today’s regular session. Past price movements do not guarantee future results.

3.What is BEAT pre-market price?

As of 2026-10-05 15:36:38, BEAT is trading at $ 0.79 in pre-market trading, up 82.24% ($0.36) from the previous close of $ 0.43. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BEAT after-hours price?

As of 2026-10-05 15:36:38, BEAT is trading at $ 0.44 in after-hours trading, up 1.24% ($0.01) from the regular-session close of $ 0.43. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BEAT stock trading now?

BEAT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BEAT sit relative to its 52-week high and low?

Over the past 52 weeks, BEAT has traded between a low of $ 0.36 and a high of $ 4.00. At $ 0.69, the stock is positioned 9.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Heartbeam, Inc. in?

Heartbeam, Inc. (BEAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Heartbeam, Inc.'s market capitalization and where is it listed?

Heartbeam, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 24.49M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BEAT valued in terms of P/E ratio and EPS?

BEAT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.36. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Heartbeam, Inc. pay a dividend?

Heartbeam, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.